New simple way to reset cells could be transplant "game changer"

January 29, 2014 by Richard Ingham
A scientific researcher extracts the RNA from embryonic stem cells in a laboratory, at the Univestiry of Sao Paulo's human genome research center, in Sao Paulo, Brazil, on March 4, 2008

Scientists Wednesday reported a simple way to turn animal cells back to a youthful, neutral state, a feat hailed as a "game-changer" in the quest to grow transplant tissue in the lab.

The research, reported in the journal Nature, could be the third great advance in stem cells—a futuristic field that aims to reverse Alzheimer's, cancer and other crippling or lethal diseases.

The latest breakthrough comes from Japan, as did its predecessor which earned its inventor a Nobel Prize.

The new approach—provided it overcomes safety hurdles—could smash cost and technical barriers in stem-cell research, said independent commentators.

"If it works in man, this could be the game-changer that ultimately makes a wide range of cell therapies available using the patient's own cells as starting material," said Chris

Mason, a professor of regenerative medicine at University College London.

"The age of personalised medicine will have arrived."

Stem cells are that, as they grow, differentiate into the various specialised cells that make up the different organs—the brain, the heart, kidney and so on.

The goal is to create stem cells in the lab and nudge them to grow into these , thus replenishing organs damaged by disease or accident.

This handout picture, released from Kyoto University on October 5, 2012 shows a mouse (R) which was born from an egg cell, made from indiced pluripotent stem (iPS) cells of a mouse, and this mouse's offspring

One of the obstacles, though, is ensuring that these transplanted cells are not attacked as alien by the body's immune system.

To achieve that, the stem cells would have to carry the patient's own genetic code, to identify them as friendly.

In 1998 came the first gain: the use of cloning technology—pioneered with Dolly the sheep—to harvest stem cells from early-stage embryos grown from the donor's own DNA.

Hugely versatile, these "pluripotent" stem cells are controversial as the method entails destroying the embryo, something opposed by religious conservatives and others.

In 2006, a team led by Shinya Yamanaka of Kyoto University, who was a co-recipient of the 2012 Nobel Prize for Medicine, created so-called induced (iPS).

Scientists work on stem cell cultures at the Transplantation Biology Research Centre situated at The Institute of Kidney Disease and Research Centre (IKDRC), Civil Hospital campus in Ahmedabad on February 6, 2013

With this, the team took and coded them with four genes, "rewinding" the cells' genetic programmes to return them to a juvenile state.

The technique had to overcome an early hurdle of causing tumours in cells and still faces problems with efficiency—less than one percent of typically are reprogrammed successfully.

The latest breakthrough, pioneered by Haruko Obokata at the RIKEN Center for Developmental Biology in Kobe, takes an entirely different and surprisingly low-tech approach.

'Hallmarks of pluripotency'

White blood cells in newborn mice were returned to a versatile state by incubating them in a solution with high acidity for 25 minutes, followed by a five minute spin in a centrifuge and a seven-day spell of immersion in a growth culture.

Called stimulus-triggered acquisition of pluripotency (STAP) cells, the innovation breaks new ground.

A scientific researcher manipulates drops of embryonic stem cells in a laboratory, at 'Hospital do Coracao' heart institute, in Sao Paulo, Brazil, on 5 March, 2008

Until now, only plant cells, and not , have been found to reprogramme back to a youthful state through simple environmental factors.

"These STAP cells show all the hallmarks of pluripotency," Obokata said Tuesday in an Internet briefing with journalists.

STAP cells appear to have a limited ability to self-renew, and it has yet to be seen if they can be acquired from humans.

Only much later may trials in humans follow.

It took 13 years before the first trials with embryonic , and six years before the first iPS trials.

Dusko Ilic, a stem-cell scientist at Kings College London, said the approach "is indeed revolutionary."

But he cautioned: "It does not bring stem cell-based therapy closer."

"We will need to use the same precautions for the cells generated in this way as for the cells isolated from embryos or reprogrammed with a standard method," he said in comments reported by London's Science Media Centre.

Explore further: Researchers create embryonic stem cells without embryo

More information: phys.org/news/2014-01-embryoni … em-cells-embryo.html

Related Stories

Researchers create embryonic stem cells without embryo

January 29, 2014
(Phys.org) —Since the discovery of human embryonic stem cells, scientists have had high hopes for their use in treating a wider variety of diseases because they are pluripotent, which means they are capable of differentiating ...

Recommended for you

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.